<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Curr Pain Headache Rep</journal-id>
      <journal-title-group>
        <journal-title>Current Pain and Headache Reports</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1531-3433</issn>
      <issn pub-type="epub">1534-3081</issn>
      <publisher>
        <publisher-name>Current Science Inc.</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3021804</article-id>
      <article-id pub-id-type="pmid">21080113</article-id>
      <article-id pub-id-type="publisher-id">156</article-id>
      <article-id pub-id-type="doi">10.1007/s11916-010-0156-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Update on Hemicrania Continua</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cittadini</surname>
            <given-names>Elisabetta</given-names>
          </name>
          <address>
            <email>cittadin@fmrib.ox.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Goadsby</surname>
            <given-names>Peter J.</given-names>
          </name>
          <address>
            <email>pgoadsby@headache.ucsf.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Functional Magnetic Resonance Imaging of the Brain Centre, Pain Group, Oxford University, Oxford, UK </aff>
        <aff id="Aff2"><label>2</label>San Francisco, UCSF Headache Center, University of California, 1701 Divisadero Street, Suite 480, San Francisco, CA 94115 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <volume>15</volume>
      <issue>1</issue>
      <fpage>51</fpage>
      <lpage>56</lpage>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <p>Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. Most recently, detailed case series that provide more detailed information concerning the sometimes complex clinical presentation of HC have been reported. Functional imaging studies suggest a unique pattern of subcortical involvement in HC: contralateral to the pain posterior hypothalamic region, ipsilateral dorsal pons and ipsilateral ventral midbrain, which, along with the particular effect of indometacin, probably justifies its classification as a unique entity. Increasing the awareness of this primary headache form among clinicians will aid in its diagnosis while further work is being undertaken to characterize the syndrome.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Chronic daily headache</kwd>
        <kwd>Indometacin-sensitive headache</kwd>
        <kwd>Indometacin test</kwd>
        <kwd>Trigeminal autonomic cephalalgias</kwd>
        <kwd>International classification of headache disorders</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media, LLC 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>The first description of the syndrome was probably as a cluster headache variant with strictly unilateral, continuous headache responding to indometacin [<xref ref-type="bibr" rid="CR1">1</xref>]. Subsequently, the disorder was named hemicrania continua (HC) [<xref ref-type="bibr" rid="CR2">2</xref>]: the index patients were a woman (age 63&#xA0;years) and a man (age 53&#xA0;years) who developed a strictly unilateral continuous pain from onset and were completely responsive to indometacin. Interestingly, 1&#xA0;year earlier, a 49-year-old man who had a history of more than 20&#xA0;years of unilateral pain, mainly localized on the left side, and also had a dramatic response to indometacin was described [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Case Series</title>
      <p>Following the description by Sjaastad and Spierings [<xref ref-type="bibr" rid="CR2">2</xref>], more than 100 cases of HC have been described. The first case series was reported in 1991 with 18 cases reviewed from the literature [<xref ref-type="bibr" rid="CR4">4</xref>]. Newman and colleagues [<xref ref-type="bibr" rid="CR5">5</xref>] described 10 new cases and reviewed 24 cases from the literature in an attempt to better describe the clinical picture and temporal profile. In 1999, Espada and colleagues [<xref ref-type="bibr" rid="CR6">6</xref>] described the long-term outcome of the indometacin response in five men and four women. Peres and colleagues [<xref ref-type="bibr" rid="CR7">7</xref>] described 34 new cases to highlight this syndrome, and Pareja and colleagues [<xref ref-type="bibr" rid="CR8">8</xref>] reviewed 16 patients with HC to assess doses and the side effects of prolonged indometacin treatment. Bigal and colleagues [<xref ref-type="bibr" rid="CR9">9</xref>] retrospectively described 10 cases, and Wheeler [<xref ref-type="bibr" rid="CR10">10</xref>] described six cases of HC in African-Americans. Klein and colleagues [<xref ref-type="bibr" rid="CR11">11</xref>] retrospectively described eight patients with HC that had neuro-ophthalmologic presentations. In 2009, Marmura and colleagues [<xref ref-type="bibr" rid="CR12">12</xref>&#x2022;] retrospectively reviewed the clinical charts of 43 patients with positive response to indometacin versus 122 patients with a negative response to indometacin to identify possible clinical differences, which is in practice a very substantial issue. The authors compared the two groups for age, sex, presence or absence of specific autonomic symptoms, medication overuse, rapid onset of headache, and if the headaches met International Headache Society (IHS) criteria for migraine when severe. The study did not show any difference in the demographics or clinical characteristics of these two groups, supporting the clinical impression that it is challenging to identify clinical characteristics that can predict a response to indometacin. In the study, the frequent diagnosis of patients who did not respond to indometacin included chronic migraine with and without medication overuse, new daily&#x2013;persistent headache (NDPH), nummular headache, or cervicogenic headache [<xref ref-type="bibr" rid="CR13">13</xref>]. Further, 24 of 42 patients (57%) had cranial autonomic features required by the International Classification of Headache Disorders (ICHD) [<xref ref-type="bibr" rid="CR14">14</xref>] and 55% of the patients exhibited medication overuse. In a previous study [<xref ref-type="bibr" rid="CR7">7</xref>], 25 of 34 patients (73.5%) had at least one cranial autonomic feature according to the Goadsby and Lipton criteria [<xref ref-type="bibr" rid="CR15">15</xref>], and in the most recent study [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], 37 of 39 patients (95%) with HC had at least one cranial autonomic feature. However, some of the features in the cohort are not in the current diagnostic criteria, including forehead/facial flushing, itching of the eye, eyelid edema, and a sense of aural fullness or swelling. In addition, 3 of 39 patients had side-shifting pain, and there are reports of patients with side-shifting pain in the literature [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;]. Overall, it emerged that some of the current criteria for HC [<xref ref-type="bibr" rid="CR14">14</xref>] are restrictive and that there is a need for the revision of the current criteria.</p>
    </sec>
    <sec id="Sec3">
      <title>Epidemiology and Sex Distribution</title>
      <p>The incidence and prevalence of HC is unknown. Initially, it was considered to be a very rare syndrome. However, the increasing number of patients identified in headache subspecialty clinics has led some to suggest the condition may be underdiagnosed [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. On the other hand, the diagnosis of a relatively small group of patients with HC over a period of 13&#xA0;years [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;] in a tertiary center, using strict indometacin-response criteria, suggests the condition is rare. Only a large population-based study will properly provide clear information about the prevalence of this condition. In the latest study of 39 patients with HC [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], the range of headache onset was between 10 and 67&#xA0;years, and this data confirms the existing literature that states this condition can begin at any age; the mean age at onset is in the 30&#xA0;s. In the Vaga study [<xref ref-type="bibr" rid="CR18">18</xref>], one patient had a clinical picture that resembled HC, but the indometacin trial was not attempted to confirm the diagnosis. This data suggests that the prevalence of HC is possibly no more than 1 in 1838: in effect, a rare condition.</p>
      <p>A preponderance of women (5:1) initially was noted in the first 18 cases reported by Bordini and colleagues [<xref ref-type="bibr" rid="CR4">4</xref>]. However, the female preponderance has decreased with more reported cases to 1.8:1 [<xref ref-type="bibr" rid="CR5">5</xref>]. In a study of 34 patients, the female-to-male ratio was 2.4:1 [<xref ref-type="bibr" rid="CR7">7</xref>], and in the recent study of 39 patients [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], there was a small female preponderance (1.6:1), which is in line with the literature and is less than is seen in patients with migraine.</p>
    </sec>
    <sec id="Sec4">
      <title>Family History and Genetics</title>
      <p>A family history of clear HC has not been reported in the available literature. Pareja and colleagues [<xref ref-type="bibr" rid="CR19">19</xref>] described a patient with episodic HC who had a sister with HC, but unfortunately, detailed information regarding the headache was not reported. In 1999, a case report describing a coincidental occurrence of familial hemiplegic migraine and primary HC was suggested to be unlikely to be due to chance because of a very low incidence of both headache types, suggesting a common pathophysiological link [<xref ref-type="bibr" rid="CR20">20</xref>]. Specific genetic studies have not been carried out in HC, and the rarity of this disorder will make this difficult. In the study of 39 patients with HC [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], the relationship between the presence of migrainous biology was assessed and it was found that migraine or headache not otherwise specified was present in the family history of 61% of patients. However, this data does not exclude the possibility that some of the relatives could have HC because the trial was not assessed due to the design of the study. Therefore, future studies should focus on performing an indometacin trial on the relatives of patients with HC who have a clinical picture suggestive of HC.</p>
    </sec>
    <sec id="Sec5">
      <title>Pathophysiology</title>
      <p>The pathophysiology of HC is poorly understood. Craniovascular involvement has been investigated with orbital phlebography in six patients, but only in one patient was there an abnormality consisting of bilateral narrowing of the ophthalmic veins, which may have been a nonspecific finding with unilateral pain [<xref ref-type="bibr" rid="CR21">21</xref>]. The pain pressure thresholds are reported to be reduced in patients with HC [<xref ref-type="bibr" rid="CR22">22</xref>], similar to cases of paroxysmal hemicrania and cluster headache (CH) [<xref ref-type="bibr" rid="CR23">23</xref>]. Pupillometric studies have shown no clear abnormality in HC [<xref ref-type="bibr" rid="CR24">24</xref>], and studies of facial sweating have shown modest changes similar to those seen in PH [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
      <p>An important development resulting in greater insight into the pathophysiology of primary headache syndrome comes from functional brain imaging that suggested a role for subcortical neural structures [<xref ref-type="bibr" rid="CR26">26</xref>]. A positron emission tomography study in HC showed activation of the contralateral posterior hypothalamus, with correlates with hypothalamic activation in CH and the trigeminal autonomic cephalalgias (TACs), and also in the dorsal rostral pons, ventrolateral midbrain (extending over the red nucleus and substantia nigra), and pontomedullary junction [<xref ref-type="bibr" rid="CR27">27</xref>]. The ipsilateral dorsal pontine region is similar to that seen in migraine [<xref ref-type="bibr" rid="CR28">28</xref>&#x2013;<xref ref-type="bibr" rid="CR30">30</xref>]. These findings, together with the clinical phenotype, suggest HC is unique and overlaps with both TACs and migraine. The complete response to indometacin may be due in part to the activation of the ventral midbrain, red nucleus, and substantia nigra, which is active during the painful exacerbation of HC and inactive after indometacin administration. It is interesting that TACs and HC show activation of posterior hypothalamus and prominent cranial autonomic features are present in association with headache.</p>
      <p>It has been suggested the cranial autonomic features may be prominent in these syndromes owing to central disinhibition of the trigeminal-autonomic reflex by the hypothalamus [<xref ref-type="bibr" rid="CR31">31</xref>]. Indeed, there are direct hypothalamic&#x2013;trigeminal connections [<xref ref-type="bibr" rid="CR32">32</xref>], and the hypothalamus is known to have a modulatory role on the nociceptive pathways [<xref ref-type="bibr" rid="CR33">33</xref>]. The activation of the region of the posterior hypothalamus observed in the TACs and HC with neuroimaging studies underlines an important role in the primary headache syndromes for this region. Only further studies and detailed anatomical work will allow us to understand the role of the region more completely in HC and indeed, more broadly in the TACs.</p>
    </sec>
    <sec id="Sec6">
      <title>Clinical Features and Diagnosis</title>
      <p>The current second edition of the ICHD [<xref ref-type="bibr" rid="CR14">14</xref>] defines HC by the presence of unilateral continuous daily headache without side shift. The pain is considered to be moderate in intensity, but there may be exacerbations of severe pain. During exacerbations, there should be at least one ipsilateral cranial autonomic symptom, such as conjunctival injection, lacrimation, nasal blockage, rhinorrhea, ptosis, or miosis. Cases of patients with side shift of pain have been noted [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], suggesting the condition is not side locked, and therefore, side shift of pain should not preclude an indometacin trial. The cranial autonomic features do not always occur with the exacerbation of the pain [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x2022;, <xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;] and also, during a detailed interview, a wider range of cranial autonomic features can be detected [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;]. The current IHS classification [<xref ref-type="bibr" rid="CR14">14</xref>] describes the pain as moderate in intensity with exacerbation of severe pain. From a recent cohort [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], it emerged that severe pain is reported in 70% of the patients, reinforcing the importance of timely diagnosis.</p>
      <p>In addition, it also has been suggested that unilateral photophobia or phonophobia, or both, are more frequent in HC and TACs such as CH, paroxysmal hemicrania, and SUNCT (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing) than in migraine and NDPH [<xref ref-type="bibr" rid="CR34">34</xref>]. In a cohort of 39 patients [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], 79% had phonophobia, which was unilateral in 48%, and 74% had photophobia, which was unilateral in 48%. The presence of these unilateral symptoms may be clinically useful pointers; however, further comparison studies between HC and unilateral chronic migraine are needed to confirm the clinical importance of these data.</p>
      <p>It also has emerged that more than half of the patients show signs of agitation or restlessness or both, but also, more than half of the patients have sensitivity to movement. This is useful information because it once again suggests that this condition shares some part of the TAC and migraine phenotypes, which is consistent with the functional imaging data. In the future, studies that correlate imaging and phenotype may further elucidate the basis of the symptoms our patients report.</p>
      <p>Current criteria [<xref ref-type="bibr" rid="CR14">14</xref>] for the diagnosis of HC mandate daily and continuous pain without pain-free periods for more than 3&#xA0;months. Typically, HC is a chronic condition with the episodic form occurring less often. The current classification [<xref ref-type="bibr" rid="CR14">14</xref>] does not include criteria that indicate how to classify the chronic and episodic forms based on duration and frequency of the pain. Recent data [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;] confirm that chronic HC can arise de novo (primary chronic HC), or evolve from the episodic subtype (secondary HC). In addition, episodic HC can arise de novo (primary episodic form), or some patients can switch from chronic to episodic form (secondary episodic). Most of the patients described in this cohort had the primary chronic form, which is in line with the current literature [<xref ref-type="bibr" rid="CR7">7</xref>]. At present, there is not a clear classification for these two subforms, and the authors suggested the following possible classification: the term chronic should apply to patients without pain-free periods for at least 1&#xA0;year, and the term episodic should apply to patients who have pain-free periods of at least 1&#xA0;day.</p>
    </sec>
    <sec id="Sec7">
      <title>Differential Diagnosis of Hemicrania Continua</title>
      <p>The differential diagnosis of long-lasting unilateral headache includes HC, unilateral chronic migraine, NDPH (probably largely its migrainous subtype) [<xref ref-type="bibr" rid="CR35">35</xref>], and the other TACs when they occur with background pain, notably paroxysmal hemicrania. HC can be differentiated from chronic migraine and NDPH by the positive response to indometacin [<xref ref-type="bibr" rid="CR35">35</xref>]. The differential diagnosis between HC and paroxysmal hemicrania with interictal pain can be difficult, and certainly, a headache diary is very useful during the workup of HC. In our experience, HC typically has less prominent cranial autonomic features than paroxysmal hemicrania. Furthermore, the background pain in HC is typically more severe than the interictal pain in paroxysmal hemicrania. In addition, painful exacerbations in HC are long lasting, usually several hours, and less frequent, whereas those in paroxysmal hemicrania are short lasting, typically a few minutes to 1&#xA0;h, and occur many times a day. In general, a careful history supplemented with a headache diary allows these two headache types to be dissected one from another (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Comparison based on the cohorts of patients with trigeminal autonomic cephalalgia and hemicrania continua</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Headache characteristics</th><th>Cluster headache[<xref ref-type="bibr" rid="CR44">44</xref>]</th><th>Paroxysmal hemicrania [<xref ref-type="bibr" rid="CR45">45</xref>]</th><th>SUNCT/SUNA [<xref ref-type="bibr" rid="CR46">46</xref>]</th><th>Hemicrania continua [<xref ref-type="bibr" rid="CR16">16</xref>]</th></tr></thead><tbody><tr><td>Sex, M:F</td><td>3:1</td><td>1:1</td><td>1.5:1</td><td>1:1.6</td></tr><tr><td colspan="5">Pain</td></tr><tr><td>&#xA0;&#x2022; Quality</td><td>Sharp/stabbing/throbbing</td><td>Sharp/stabbing/throbbing</td><td>Sharp/stabbing/throbbing</td><td>Throbbing/sharp/constant</td></tr><tr><td>&#xA0;&#x2022; Severity</td><td>Very severe</td><td>Very severe</td><td>Severe</td><td>Moderate/severe/very severe</td></tr><tr><td>&#xA0;&#x2022; Distribution<sup>a</sup></td><td>V1 &gt;C2 &gt; V2 &gt; V3</td><td>V1 &gt; C2 &gt; V2 &gt; V3</td><td>V1 &gt; C2 &gt; V2 &gt; V3</td><td>V1 &gt; C2 &gt; V2 &gt; V3</td></tr><tr><td colspan="5">Attacks</td></tr><tr><td>&#x2022; Frequency (per day)</td><td>1&#x2013;8</td><td>11</td><td>100</td><td>No pattern</td></tr><tr><td>&#x2022; Length, min</td><td>30&#x2013;180</td><td>2&#x2013;50</td><td>1&#x2013;5</td><td>30&#xA0;min&#x2013;7&#xA0;days Background pain</td></tr><tr><td colspan="5">Triggers</td></tr><tr><td>&#xA0;&#x2022; Alcohol</td><td>+ + +</td><td>+</td><td>&#x2013;</td><td>+</td></tr><tr><td>&#xA0;&#x2022; Nitroglycerin</td><td>+ + +</td><td>+</td><td>&#x2013;</td><td>+ +</td></tr><tr><td>&#xA0;&#x2022; Cutaneous</td><td>&#x2013;</td><td>&#x2013;</td><td>+ + +</td><td>&#x2013;</td></tr><tr><td>Agitation/restlessness</td><td>90%</td><td>80%</td><td>65%</td><td>69%</td></tr><tr><td>Episodic vs chronic, E:C</td><td>90:10</td><td>35:65</td><td>10:90</td><td>18:82</td></tr><tr><td>Circadian/circannual periodicity</td><td>Present</td><td>Absent</td><td>Absent</td><td>Absent</td></tr><tr><td colspan="5">Treatment effects</td></tr><tr><td>&#xA0;&#x2022; Oxygen</td><td>70%</td><td>No effect</td><td>No effect</td><td>No effect</td></tr><tr><td>&#xA0;&#x2022; Sumatriptan, 6&#xA0;mg</td><td>90%</td><td>20%</td><td>&lt; 10%</td><td>No effect</td></tr><tr><td>&#xA0;&#x2022; indometacin</td><td>No effect</td><td>100%</td><td>No effect</td><td>100%</td></tr><tr><td colspan="5">Migraine features with attacks</td></tr><tr><td>&#xA0;&#x2022; Nausea</td><td>50%</td><td>40%</td><td>25%</td><td>53%</td></tr><tr><td>&#xA0;&#x2022; Photophobia/phonophobia</td><td>65%</td><td>65%</td><td>25%</td><td>80%</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup><italic>C</italic> cervical, <italic>V</italic> trigeminal</p><p><italic>SUNA</italic> short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms, <italic>SUNCT</italic> short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8">
      <title>Diagnosis and Investigations</title>
      <p>The diagnosis is made on the basis of clinical history, neurological examination, and a therapeutic trial with indometacin. The indometacin test can be performed in two different ways: by making use of an oral trial or a placebo-controlled Indotest test [<xref ref-type="bibr" rid="CR16">16</xref>]. The mean daily dosage in one cohort was 137&#xA0;mg with a range of 25&#x2013;225&#xA0;mg [<xref ref-type="bibr" rid="CR7">7</xref>]. In another cohort of 39 patients with HC [<xref ref-type="bibr" rid="CR16">16</xref>], all patients (81%) who could tolerate oral indometacin had an absolute response to the oral trial. The range of effective daily doses in our cohort varied between 50&#xA0;mg to 500&#xA0;mg per day. Some three quarters of patients reported side effects at some point, whereas only about a quarter of patients reported side effects during the placebo-controlled Indotest. The latter consists of parenteral single-blind administration of indometacin, 100 or 200&#xA0;mg, or placebo. The authors suggest the placebo-controlled indometacin test may be the gold standard when applied, facilitating diagnosis and research. An important question [<xref ref-type="bibr" rid="CR12">12</xref>&#x2022;] that has emerged and has not been addressed yet is whether medication overuse, in particular opioids, can influence the response to indometacin [<xref ref-type="bibr" rid="CR36">36</xref>]. Medication overuse also has been reported in patients with HC [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;, <xref ref-type="bibr" rid="CR37">37</xref>] and in our practice, we prefer to stop medication overuse, where it is possible, based on the knowledge that medication can alter the clinical picture [<xref ref-type="bibr" rid="CR38">38</xref>]. Nevertheless, we performed indometacin trials in both contexts with positive and negative outcome. However, in our original study [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], we did not specifically address this question. Future clinical and animal studies are needed to advance the knowledge in this specific field.</p>
      <p>HC is a debilitating condition [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;], but a recent study clearly showed that it still is misdiagnosed. In fact, in a cohort of 25 patients [<xref ref-type="bibr" rid="CR39">39</xref>&#x2022;], not one had received the correct diagnosis before attending the headache center. Interestingly, 85% of the patients were assessed by a physician within 6&#xA0;months of the onset of symptoms, but the mean latency of diagnosis was 5&#xA0;years, with the average number of physicians seen before the headache was correctly diagnosed being 4.6&#x2009;&#xB1;&#x2009;2.2&#xA0;years. A prompt diagnosis would save hospital resources and relieve the patients more quickly.</p>
    </sec>
    <sec id="Sec9">
      <title>Treatment</title>
      <p>There is no other drug that is consistently effective in HC. The essential management problem arises when indometacin produces peptide ulcer disease. Again, the cyclooxygenase-2 inhibitors seemed to offer a way forward, but are no longer recommended. Topiramate has been reported to be useful in HC [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>] and this is born out in practice. Similarly, greater occipital nerve injection with lidocaine and methylprednisolone has been reported to be helpful [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
      <p>In 2008, Burns and colleagues [<xref ref-type="bibr" rid="CR43">43</xref>&#x2022;&#x2022;] prospectively described a cohort of six patients with HC that underwent occipital nerve stimulation with a bion device. They found that in a long-term follow-up, four of six patients reported a substantial improvement (80%&#x2013;90%), one patient reported a 30% improvement, and one patient reported that his pain was worse by 20%. The authors suggested the new miniaturized device was safe and effective as it represents a potential new option for the treatment of HC.</p>
    </sec>
    <sec id="Sec10">
      <title>Conclusions</title>
      <p>Since Sjaastad and Spierings [<xref ref-type="bibr" rid="CR2">2</xref>] first coined the term in 1984, our knowledge&#x2009;of HC has progressed considerably in understanding both the pathophysiology and clinical presentation. It is a severe and disabling condition that deserves a prompt diagnosis. Amendments to the current criteria have been proposed based on the clinical data from a substantial cohort [<xref ref-type="bibr" rid="CR16">16</xref>&#x2022;&#x2022;]. The gold standard treatment is indometacin, and occipital nerve stimulation may represent a valid option in a select&#x2009;group of patients. Future directions also will include clinical studies that try to identify possible markers that can help during the differential diagnosis between HC and unilateral chronic migraine and studies that evaluate whether medication overuse, specifically opioids, can alter the response to indometacin. We suggest that a placebo-controlled indometacin test should be considered the gold standard when applied, facilitating diagnosis and research. We also draw attention to the need&#x2009;for more neurologists and general practitioners to have headache training to reduce the number of patients who still are misdiagnosed.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Disclosures</bold> Dr. E. Cittadini: none; Dr. Peter J. Goadsby has served as a board member for Allergan; CoLucid Pharmaceuticals; MAP Pharmaceuticals, Inc.; Merck, Sharpe, and Dohme; Neuralieve; NeurAxon; ATI Pharmaceuticals; Minster Pharmaceuticals; Boehringer-Ingelheim; Boston Scientific; Coherex; Eli Lilly and Co.; Medtronic; and Linde Industrial Gases; has served as a consultant for Bristol-Myers Squibb, Pfizer, NeuroTherapeutics Pharma, Vertex Pharmaceuticals, Valeant, AstraZeneca, and Kalypsys; has provided expert testimony on behalf of MedicoLegal; has received grants or has grants pending with GlaxoSmithKline; MAP Pharmaceuticals, Inc.; Merck, Sharpe, and Dohme; Neuralieve; and Boston Scientific; has received payment for speaking from Merck, Sharpe, and Dohme and Almirall; and has received payment for the development of educational presentations from the American Headache Society.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref-list id="BSec1">
        <title>Papers of particular interest, published in the last 3&#xA0;years, have been highlighted as: &#x2022; Of importance, &#x2022;&#x2022; Of major importance</title>
        <ref id="CR1">
          <label>1.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Medina</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cluster headache variant: spectrum of a new headache syndrome</article-title>
            <source>Archives of Neurology</source>
            <year>1981</year>
            <volume>38</volume>
            <fpage>705</fpage>
            <lpage>709</lpage>
            <pub-id pub-id-type="pmid">7305699</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR2">
          <label>2.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Sjaastad</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Spierings</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua: another headache absolutely responsive to indomethacin</article-title>
            <source>Cephalalgia</source>
            <year>1984</year>
            <volume>4</volume>
            <fpage>65</fpage>
            <lpage>70</lpage>
            <pub-id pub-id-type="pmid">6713526</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR3">
          <label>3.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Boghen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Desaulniers</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Background vascular headache: relief with indomethacin</article-title>
            <source>Can J Neurol Sci</source>
            <year>1983</year>
            <volume>10</volume>
            <fpage>270</fpage>
            <lpage>271</lpage>
            <pub-id pub-id-type="pmid">6360321</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR4">
          <label>4.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Bordini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stovner</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Schrader</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sjaastad</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>"Hemicrania continua": a clinical review</article-title>
            <source>Headache</source>
            <year>1991</year>
            <volume>31</volume>
            <fpage>20</fpage>
            <lpage>26</lpage>
            <pub-id pub-id-type="pmid">2016164</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR5">
          <label>5.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Newman</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Lipton</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua: ten new cases and a review of the literature</article-title>
            <source>Neurology</source>
            <year>1994</year>
            <volume>44</volume>
            <fpage>2111</fpage>
            <lpage>2114</lpage>
            <pub-id pub-id-type="pmid">7969968</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR6">
          <label>6.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Espada</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Escalza</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Morales-Asin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nasas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Inignez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua: nine new cases</article-title>
            <source>Cephalalgia</source>
            <year>1999</year>
            <volume>19</volume>
            <fpage>442</fpage>
          </mixed-citation>
        </ref>
        <ref id="CR7">
          <label>7.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Peres</surname>
                <given-names>MFP</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Nahmias</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sechter</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Youssef</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rozen</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua is not that rare</article-title>
            <source>Neurology</source>
            <year>2001</year>
            <volume>57</volume>
            <fpage>948</fpage>
            <lpage>951</lpage>
            <pub-id pub-id-type="pmid">11577748</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR8">
          <label>8.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Pareja</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The hemicrania continua diagnosis</article-title>
            <source>Cephalalgia</source>
            <year>2001</year>
            <volume>21</volume>
            <fpage>940</fpage>
            <lpage>946</lpage>
            <pub-id pub-id-type="pmid">11843864</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR9">
          <label>9.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Bigal</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Tepper</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Rapoport</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Sheftell</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua: comparison between two different classification systems</article-title>
            <source>Cephalalgia</source>
            <year>2002</year>
            <volume>22</volume>
            <fpage>242</fpage>
            <lpage>245</lpage>
            <pub-id pub-id-type="pmid">12047465</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR10">
          <label>10.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Wheeler</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua in African Americans</article-title>
            <source>J Natl Med Assoc</source>
            <year>2002</year>
            <volume>94</volume>
            <fpage>901</fpage>
            <lpage>907</lpage>
            <pub-id pub-id-type="pmid">12408695</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR11">
          <label>11.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Klein</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kostina-O'Neil</surname>
                <given-names>Y</given-names>
              </name>
              <etal/>
            </person-group>
            <article-title>Neuro-ophthalmologic presentations of hemicrania continua</article-title>
            <source>Am J Ophthalmol</source>
            <year>2006</year>
            <volume>141</volume>
            <fpage>88</fpage>
            <lpage>92</lpage>
            <pub-id pub-id-type="pmid">16386981</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR12">
          <label>12.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Marmura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua: who responds to indomethacin?</article-title>
            <source>Cephalalgia</source>
            <year>2009</year>
            <volume>29</volume>
            <fpage>300</fpage>
            <lpage>307</lpage>
            <pub-id pub-id-type="pmid">19220311</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR13">
          <label>13.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Prakash</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Marmura</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua unresponsive to indomethacin do exist</article-title>
            <source>Cephalalgia</source>
            <year>2010</year>
            <volume>30</volume>
            <fpage>123</fpage>
            <lpage>125</lpage>
            <pub-id pub-id-type="pmid">20511195</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR14">
          <label>14.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <collab>Headache Classification Committee of The International Headache Society</collab>
            </person-group>
            <article-title>The International Classification of Headache Disorders (second edition)</article-title>
            <source>Cephalalgia</source>
            <year>2004</year>
            <volume>24</volume>
            <fpage>1</fpage>
            <lpage>160</lpage>
          </mixed-citation>
        </ref>
        <ref id="CR15">
          <label>15.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Lipton</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases</article-title>
            <source>Brain</source>
            <year>1997</year>
            <volume>120</volume>
            <fpage>193</fpage>
            <lpage>209</lpage>
            <pub-id pub-id-type="pmid">9055807</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR16">
          <label>16.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Cittadini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania Continua: A clinical study of 39 patients with diagnostic implications</article-title>
            <source>Brain</source>
            <year>2010</year>
            <volume>133</volume>
            <fpage>1973</fpage>
            <lpage>1986</lpage>
            <pub-id pub-id-type="pmid">20558416</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR17">
          <label>17.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Wheeler</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical spectrum of hemicrania continua</article-title>
            <source>Neurology</source>
            <year>2000</year>
            <volume>54</volume>
            <fpage>422</fpage>
          </mixed-citation>
        </ref>
        <ref id="CR18">
          <label>18.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Sjaastad</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pettersen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bakketeig</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>The Vaga study; epidemiology of headache I: the prevalence of ultrashort paroxysms</article-title>
            <source>Cephalalgia</source>
            <year>2001</year>
            <volume>21</volume>
            <fpage>207</fpage>
            <lpage>215</lpage>
            <pub-id pub-id-type="pmid">11442556</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR19">
          <label>19.</label>
          <mixed-citation publication-type="other">Pareja JA, Palomo T, Gorriti MA, Pareja J, Espejo J: Hemicrania episodica-- a new type of headache or a pre-chronic stage of hemicrania continua. Headache 1990 1990, 30:344-346.</mixed-citation>
        </ref>
        <ref id="CR20">
          <label>20.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Evers</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bahra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Coincidence of familial hemiplegic migraine and hemicrania continua? A case report</article-title>
            <source>Cephalalgia</source>
            <year>1999</year>
            <volume>19</volume>
            <fpage>533</fpage>
            <lpage>535</lpage>
            <pub-id pub-id-type="pmid">10403071</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR21">
          <label>21.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Chronic paroxysmal hemicrania and hemicrania continua: orbital phlebography and MRI studies</article-title>
            <source>Headache</source>
            <year>1994</year>
            <volume>34</volume>
            <fpage>32</fpage>
            <lpage>34</lpage>
            <pub-id pub-id-type="pmid">8132437</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR22">
          <label>22.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sandrini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Danilov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sand</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua</article-title>
            <source>Headache</source>
            <year>1994</year>
            <volume>34</volume>
            <fpage>479</fpage>
            <lpage>483</lpage>
            <pub-id pub-id-type="pmid">7960734</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR23">
          <label>23.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sandrini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pucci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arrigo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Micieli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nappi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lateralization of pain pressure threshold in cluster headache</article-title>
            <source>Cephalalgia</source>
            <year>1993</year>
            <volume>13</volume>
            <fpage>33</fpage>
            <pub-id pub-id-type="pmid">8448786</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR24">
          <label>24.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sand</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sjaastad</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua and chronic paroxysmal hemicrania: a comparison of pupillometric findings</article-title>
            <source>Functional Neurology</source>
            <year>1992</year>
            <volume>7</volume>
            <fpage>385</fpage>
            <lpage>389</lpage>
            <pub-id pub-id-type="pmid">1292959</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR25">
          <label>25.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Antonaci</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The sweating pattern in hemicrania continua</article-title>
            <source>A comparison with chronic paroxysmal hemicrania. Functional Neurology</source>
            <year>1991</year>
            <volume>6</volume>
            <fpage>371</fpage>
            <lpage>375</lpage>
          </mixed-citation>
        </ref>
        <ref id="CR26">
          <label>26.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Functional neuroimaging of primary headache disorders</article-title>
            <source>Expert Review in Neurotherapeutics</source>
            <year>2006</year>
            <volume>6</volume>
            <fpage>1159</fpage>
            <lpage>1172</lpage>
          </mixed-citation>
        </ref>
        <ref id="CR27">
          <label>27.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>McGonigle</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Frackowiak</surname>
                <given-names>RSJ</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Posterior hypothalamic and brainstem activation in hemicrania continua</article-title>
            <source>Headache</source>
            <year>2004</year>
            <volume>44</volume>
            <fpage>747</fpage>
            <lpage>761</lpage>
            <pub-id pub-id-type="pmid">15330820</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR28">
          <label>28.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Bahra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Buchel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frackowiak</surname>
                <given-names>RSJ</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Brainstem activation specific to migraine headache</article-title>
            <source>The Lancet</source>
            <year>2001</year>
            <volume>357</volume>
            <fpage>1016</fpage>
            <lpage>1017</lpage>
          </mixed-citation>
        </ref>
        <ref id="CR29">
          <label>29.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Afridi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giffin</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Kaube</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Friston</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Frackowiak</surname>
                <given-names>RSJ</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>A PET study in spontaneous migraine</article-title>
            <source>Archives of Neurology</source>
            <year>2005</year>
            <volume>62</volume>
            <fpage>1270</fpage>
            <lpage>1275</lpage>
            <pub-id pub-id-type="pmid">16087768</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR30">
          <label>30.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Weiller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Limmroth</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Juptner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaube</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schayck</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Coenen</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Brain stem activation in spontaneous human migraine attacks</article-title>
            <source>Nature Medicine</source>
            <year>1995</year>
            <volume>1</volume>
            <fpage>658</fpage>
            <lpage>660</lpage>
            <pub-id pub-id-type="pmid">7585147</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR31">
          <label>31.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Benjamin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lasalandra</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Akerman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Classey</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study</article-title>
            <source>Neurobiology of Disease</source>
            <year>2004</year>
            <volume>16</volume>
            <fpage>500</fpage>
            <lpage>505</lpage>
            <pub-id pub-id-type="pmid">15262261</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR32">
          <label>32.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Malick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cells of origin of the trigeminohypothalamic tract in the rat</article-title>
            <source>Journal of Comparative Neurology</source>
            <year>1998</year>
            <volume>400</volume>
            <fpage>125</fpage>
            <lpage>144</lpage>
            <pub-id pub-id-type="pmid">9762871</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR33">
          <label>33.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Bartsch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Differential modulation of nociceptive dural input to [hypocretin] Orexin A and B receptor activation in the posterior hypothalamic area</article-title>
            <source>Pain</source>
            <year>2004</year>
            <volume>109</volume>
            <fpage>367</fpage>
            <lpage>378</lpage>
            <pub-id pub-id-type="pmid">15157698</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR34">
          <label>34.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Irimia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cittadini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paemeleire</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias</article-title>
            <source>Cephalalgia</source>
            <year>2008</year>
            <volume>28</volume>
            <fpage>626</fpage>
            <lpage>630</lpage>
            <pub-id pub-id-type="pmid">18422722</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR35">
          <label>35.</label>
          <mixed-citation publication-type="other">Goadsby PJ, Boes CJ: New Daily Persistent Headache. Journal of Neurology, Neurosurgery and Psychiatry 2002, 72:ii6-ii9.</mixed-citation>
        </ref>
        <ref id="CR36">
          <label>36.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Jakubowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goor-Aryeh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bajwa</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Burstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors</article-title>
            <source>Headache</source>
            <year>2005</year>
            <volume>45</volume>
            <fpage>850</fpage>
            <lpage>861</lpage>
            <pub-id pub-id-type="pmid">15985101</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR37">
          <label>37.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Young</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Hemicrania continua and symptomatic mediation overuse</article-title>
            <source>Headache</source>
            <year>1993</year>
            <volume>33</volume>
            <fpage>485</fpage>
            <lpage>487</lpage>
            <pub-id pub-id-type="pmid">8262795</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR38">
          <label>38.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Warner</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Analgesic rebound as a cause of hemicrania continua</article-title>
            <source>Neurology</source>
            <year>1997</year>
            <volume>48</volume>
            <fpage>1540</fpage>
            <lpage>1541</lpage>
            <pub-id pub-id-type="pmid">9191763</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR39">
          <label>39.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Rossi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Faroni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tassorelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nappi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic delay and suboptimal management in a referral population with hemicrania continua</article-title>
            <source>Headache</source>
            <year>2009</year>
            <volume>49</volume>
            <fpage>227</fpage>
            <lpage>234</lpage>
            <pub-id pub-id-type="pmid">19222596</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR40">
          <label>40.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Camarda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Camarda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Monastero</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2008</year>
            <volume>110</volume>
            <fpage>88</fpage>
            <lpage>91</lpage>
            <pub-id pub-id-type="pmid">17954009</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR41">
          <label>41.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Brighina</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Palermo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosentino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fierro</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate</article-title>
            <source>Headache</source>
            <year>2007</year>
            <volume>47</volume>
            <fpage>441</fpage>
            <lpage>443</lpage>
            <pub-id pub-id-type="pmid">17371364</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR42">
          <label>42.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Afridi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Bhola</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Greater occipital nerve injection in primary headache syndromes- prolonged effects from a single injection</article-title>
            <source>Pain</source>
            <year>2006</year>
            <volume>122</volume>
            <fpage>126</fpage>
            <lpage>129</lpage>
            <pub-id pub-id-type="pmid">16527404</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR43">
          <label>43.</label>
          <mixed-citation publication-type="other">&#x2022;&#x2022; Burns B, Watkins L, Goadsby PJ: Treatment of hemicrania continua by occipital nerve stimulation using the novel bion device: long term follow up of six patients. Lancet Neurology 2008, 7:1001-1012. <italic>This is an important paper because it is the first study of patients with a bion device. The new miniaturized device was safe and effective as it represents a potential new option for the treatment of HC</italic>.</mixed-citation>
        </ref>
        <ref id="CR44">
          <label>44.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Bahra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Cluster headache: a prospective clinical study in 230 patients with diagnostic implications</article-title>
            <source>Neurology</source>
            <year>2002</year>
            <volume>58</volume>
            <fpage>354</fpage>
            <lpage>361</lpage>
            <pub-id pub-id-type="pmid">11839832</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR45">
          <label>45.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Cittadini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Paroxysmal hemicrania: a prospective clinical study of thirty-one cases</article-title>
            <source>Brain</source>
            <year>2008</year>
            <volume>131</volume>
            <fpage>1142</fpage>
            <lpage>1155</lpage>
            <pub-id pub-id-type="pmid">18252775</pub-id>
          </mixed-citation>
        </ref>
        <ref id="CR46">
          <label>46.</label>
          <mixed-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA): a prospective clinical study of SUNCT and SUNA</article-title>
            <source>Brain</source>
            <year>2006</year>
            <volume>129</volume>
            <fpage>2746</fpage>
            <lpage>2760</lpage>
            <pub-id pub-id-type="pmid">16905753</pub-id>
          </mixed-citation>
        </ref>
      </ref-list>
    </ref-list>
  </back>
</article>
